Moderna seeks emergency FDA approval to vaccinate 12- to 17-year-olds

The vaccine maker says its vaccine is effective among teenagers.

Erin Carson Former Senior Writer
Erin Carson covered internet culture, online dating and the weird ways tech and science are changing your life.
Expertise Erin has been a tech reporter for almost 10 years. Her reporting has taken her from the Johnson Space Center to San Diego Comic-Con's famous Hall H. Credentials
  • She has a master's degree in journalism from Syracuse University.
Erin Carson

An injection at a mass vaccination site in March at the Circuit of the Americas racetrack in Austin, Texas.

Natalie Weinstein/CNET

Teenagers could be that much closer to getting the Moderna COVID-19 vaccine. 

Moderna is applying for emergency authorization from the US Food and Drug Administration for use of its vaccine for teenagers ages 12 to 17, the company said Thursday in a statement.

"We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents," said Moderna CEO Stéphane Bancel in the statement. 

The application follows news at the end of May from Moderna that the vaccine is effective in teenagers. Vaccine maker Pfizer received final approval in mid-May for its vaccine for those ages 12 to 15.

The Biden administration said Wednesday that it would donate 500 million doses of the Pfizer vaccine to the world's lowest-income nations over the next year.